Learning how to invest in marijuana involves more than finding a cannabis company and buying its shares. The sector includes businesses involved in cultivation and retail, pharmaceutical research, equipment, technology, real estate, and other services. Investors may also encounter companies trading on different exchanges or in over-the-counter markets.
Another complication is regulation. Cannabis laws continue to develop at the federal and state levels in the United States, creating risks that investors do not encounter in many established industries.
If you're considering cannabis investing, start by understanding the different ways to gain exposure, how to research an investment, and how regulatory and company-specific risks may affect your money.
How to Invest in Marijuana Through Stocks and ETFs
For most individual investors using publicly traded securities, there are two straightforward approaches: buying individual marijuana stocks or purchasing a fund that provides cannabis-related exposure.
Neither approach eliminates risk.
1. Individual Cannabis Stocks
Buying individual cannabis stocks gives you direct exposure to particular publicly traded businesses.
Depending on the company, its activities might include:
- cannabis cultivation
- retail dispensaries
- pharmaceutical or cannabinoid research
- agricultural equipment
- hydroponic systems
- real estate
- packaging
- software and technology
- other services supplied to cannabis businesses
Individual stocks allow you to decide exactly which businesses you want to own. The trade-off is that you need to research each company separately.
Company performance can differ substantially even when two businesses operate in the same sector.
2. Cannabis ETFs
Cannabis ETFs offer another route.
An exchange-traded fund pools investors' money and holds a portfolio of securities or other permitted assets. Investors buy and sell ETF shares through exchanges, typically using brokerage accounts.
An ETF can make it easier to own several companies through one investment. However, an industry-specific ETF should not automatically be considered broadly diversified.
A cannabis fund may remain heavily concentrated in one sector, meaning industry-wide problems could affect many of its holdings simultaneously.
Before buying one, review:
- its current holdings
- investment objective
- expense ratio
- geographic exposure
- concentration among its largest positions
- trading volume
- historical volatility
- prospectus and shareholder reports
ETFs also have costs. Fund operating expenses reduce investment returns, and investors may face additional transaction-related costs depending on their broker and the fund.
Marijuana Stocks vs. Cannabis ETFs
Choosing between stocks and funds depends partly on how much company research and concentration risk you are comfortable taking.
| Consideration | Individual Marijuana Stocks | Cannabis ETFs |
|---|---|---|
| Number of companies | Usually one per purchase | Potentially multiple holdings |
| Company selection | Investor chooses | Fund strategy determines holdings |
| Company-specific risk | Higher when concentrated | Spread among holdings, but sector risk remains |
| Research required | Company-by-company analysis | Fund, holdings, fees, and strategy analysis |
| Ongoing fund expenses | None at stock level | Typically includes fund expenses |
| Sector concentration | Depends on portfolio | Can remain highly concentrated |
| Potential loss | Investment can lose substantial value | Fund can also lose substantial value |
An ETF can spread exposure among several companies, but simply owning a fund does not remove concentration risk. A narrowly focused cannabis fund can still decline sharply if conditions across the cannabis industry deteriorate.
Understand What Type of Cannabis Business You're Buying
A useful step when learning how to invest in marijuana is identifying exactly how a company makes money.
Not every company associated with cannabis has the same business model or regulatory exposure.
Cultivators and Retailers
These businesses may grow, process, distribute, or sell marijuana within markets where their activities are permitted.
Their financial results can depend on factors such as:
- state regulations
- licensing
- taxation
- wholesale and retail prices
- production expenses
- competition
- access to capital
- consumer demand
The rules governing these businesses vary by jurisdiction, so investors should examine the markets in which each company actually operates.
Pharmaceutical and Research Companies
Another segment includes businesses developing cannabinoid-related drugs or conducting pharmaceutical research.
These companies can have very different economics from growers or dispensary operators. Investors may need to evaluate clinical development, intellectual property, regulatory approvals, cash reserves, and other characteristics common to biotechnology investments.
FDA distinguishes marijuana itself from FDA-approved drugs containing cannabis-derived or cannabis-related substances. FDA says it has not approved cannabis itself for treating any disease or condition, although specific cannabis-derived and cannabis-related prescription drugs have received approval.
Ancillary Cannabis Businesses
Some businesses sell goods or services to cannabis operators without selling marijuana themselves.
Examples may include:
- cultivation equipment
- agricultural supplies
- packaging
- software
- security services
- commercial real estate
- other business services
Ancillary businesses may have different regulatory exposure from companies directly handling marijuana, but that does not make their stocks automatically safer.
An ancillary company's results can still depend heavily on spending and expansion throughout the cannabis sector.
Check Where a Marijuana Stock Trades
Investors shouldn't assume every cannabis-related security trades on a major U.S. stock exchange.
Some securities may trade over the counter rather than on an exchange. Others may have their primary listings outside the United States.
This distinction matters.
FINRA warns that OTC equities can have less liquidity and greater volatility than many exchange-listed stocks. Some OTC issuers also have more limited publicly available information because not every OTC company is required to make the same SEC filings as companies listed on U.S. exchanges.
Before opening a position, check:
- Where does the security trade?
- Does your brokerage support it?
- Does the company file reports with the SEC?
- How liquid is the security?
- What trading fees or restrictions apply?
- Are recent financial statements readily available?
These checks are especially important with low-priced or lightly traded securities.
Be Especially Careful With Penny and Microcap Stocks
Low share price does not necessarily mean a stock is inexpensive in terms of valuation.
FINRA notes that penny stocks are typically securities issued by very small companies trading for less than $5 per share. Low-priced securities can be legitimate investments, but they may also carry substantial volatility, liquidity, disclosure, and manipulation risks.
Cannabis has previously attracted investment promotions and scams. The SEC has specifically warned investors about fraud and market manipulation involving marijuana-related investments.
Warning signs can include:
- promises of unusually high or guaranteed returns
- unsolicited investment pitches
- limited financial information
- frequent changes in a company's name or business model
- promotional claims that are difficult to verify
- unusually aggressive social-media promotion
A low stock price alone should never be the reason to buy.
Research the Company Before Making a Marijuana Investment
A marijuana investment should be evaluated using many of the same principles applied to other businesses.
Start with the company's official financial filings when available.
Revenue and Growth
Look at revenue across several reporting periods instead of focusing on one quarter.
Ask:
- Is revenue increasing or decreasing?
- Is growth coming from existing operations or acquisitions?
- Are gross margins improving?
- Is the company dependent on one geographic market?
Revenue growth can be encouraging, but growing sales do not automatically produce profits.
Profitability and Cash Flow
Review operating income, net income, and cash flow.
Companies that consistently consume cash may need additional financing. New equity financing can dilute existing shareholders, while additional borrowing can increase financial obligations.
Debt and Liquidity
Examine:
- total debt
- interest expense
- cash and cash equivalents
- current assets and liabilities
- upcoming debt maturities
A growing industry does not protect an individual company from financial stress.
Share Dilution
Look at the company's share count over time.
If a business repeatedly issues additional shares to raise capital, existing investors may own a progressively smaller percentage of the company.
Management
Review the backgrounds of executives and directors.
Consider their experience, previous businesses, compensation, insider ownership, and any related-party transactions disclosed in regulatory filings.
Valuation
A company's share price tells you little by itself.
Depending on the business and its financial condition, investors may examine metrics such as:
- price-to-sales ratio
- enterprise value
- operating margins
- free cash flow
- earnings multiples when meaningful
No single valuation metric works for every cannabis company.
Federal Marijuana Rules Remain an Important Investment Consideration
The federal regulatory environment deserves special attention because it changed materially in 2026.
In April 2026, the Department of Justice and DEA announced federal Schedule III treatment for FDA-approved marijuana-containing products and marijuana products subject to qualifying state-issued medical-marijuana licenses.
That action should not be confused with complete federal legalization or with the separate proceeding concerning broader marijuana rescheduling.
DEA subsequently began formal hearings in June 2026 concerning the broader proposal to move marijuana from Schedule I to Schedule III. Investors therefore need to check the latest federal rules rather than relying on older statements that simply describe all marijuana as Schedule I.
State authorization and federal regulation can also operate differently. A business permitted to operate under state law may still face federal regulatory considerations.
That legal complexity can affect company operations, financing, taxation, expansion plans, and ultimately investment valuations.
Tax Rules Can Affect Cannabis Companies
Federal taxation has historically created another unusual financial consideration for marijuana businesses.
Internal Revenue Code Section 280E restricts deductions or credits for businesses trafficking in Schedule I or Schedule II controlled substances under federal law. The IRS has stated that these restrictions apply to marijuana businesses operating in states where marijuana sales are legal when the relevant activity falls within those federal schedules.
Because the federal scheduling framework changed for certain medical marijuana products in 2026 while broader rescheduling remains under consideration, investors should avoid making blanket assumptions about how Section 280E applies to every cannabis company.
Instead, review each company's latest regulatory filings and tax disclosures for management's assessment of the rules applicable to its particular operations.
Diversification Still Matters
One of the easiest mistakes in thematic investing is putting too much money into a promising story.
Owning several marijuana companies may look diversified, but all of those businesses can still be exposed to similar regulatory, financing, pricing, and consumer-demand pressures.
FINRA describes this as concentration risk: losses can become amplified when too much of a portfolio is committed to a particular security, asset class, or market segment.
For example, owning a grower, a cannabis retailer, and a cannabis-focused ETF may still leave a portfolio heavily dependent on the same industry's fortunes.
Diversification across different companies, industries, asset classes, and potentially geographic markets can help manage concentration risk, although it cannot eliminate investment losses.
Major Risks of Cannabis Investing
Before deciding how to invest in marijuana, consider the risks alongside the potential opportunity.
Regulatory Risk
Federal and state rules can change. Licensing requirements, product regulations, taxation, and enforcement policies may affect business models and valuations.
Company Risk
A growing market does not guarantee that a particular company will succeed. Businesses can lose market share, accumulate debt, dilute shareholders, or fail.
Volatility
Emerging and speculative industries can experience substantial price swings as expectations change.
Liquidity Risk
Some OTC and thinly traded securities can be difficult to sell quickly at the price an investor expects.
Competition
Legal cannabis companies can compete against other licensed businesses as well as illicit markets. Competitive conditions vary considerably by jurisdiction.
Financing Risk
Access to financing can affect expansion and survival. Companies unable to fund operations internally may need to borrow money or issue additional shares.
Fraud and Manipulation Risk
The SEC and FINRA have warned that microcap and marijuana-related securities can attract misleading promotions and market manipulation.
A Practical Process for Investing in Marijuana
For someone who has decided cannabis exposure fits their objectives and risk tolerance, a structured process can reduce impulsive decisions.
Step 1: Decide How Much Risk You Can Accept
Determine how a speculative sector investment fits within your overall financial plan before choosing a stock.
Avoid basing the decision solely on potential returns.
Step 2: Choose Stocks or an ETF
Decide between researching individual businesses and using a fund that holds multiple securities.
If considering an ETF, examine its actual holdings rather than relying on its name.
Step 3: Verify Brokerage Access
Confirm that your brokerage supports the stock or ETF and the market on which it trades.
Also review applicable commissions, foreign-market fees, OTC fees, or other trading costs.
Step 4: Research Regulatory Filings
For U.S. reporting companies, search SEC EDGAR for documents such as:
- Form 10-K
- Form 10-Q
- Form 8-K
- proxy statements
These documents can reveal financial performance, risks, debt, litigation, executive compensation, and other information that promotional material might not emphasize.
Step 5: Review Financial Health
Look beyond revenue.
Study cash flow, profitability, debt, liquidity, margins, and changes in outstanding shares.
Step 6: Understand the Company's Regulatory Exposure
Determine where the company operates and which parts of its business involve marijuana directly.
A cultivation company can face different rules from a software provider or pharmaceutical developer.
Step 7: Keep the Position in Perspective
Consider how the investment changes your overall portfolio exposure.
Buying multiple companies from the same sector does not necessarily create meaningful diversification.
Step 8: Continue Reviewing the Investment
The reasons for owning a company can change.
Monitor:
- financial reports
- regulatory filings
- debt
- cash flow
- acquisitions
- share issuance
- management changes
- federal and state regulatory developments
An investment that made sense when purchased may not always remain suitable.
Frequently Asked Questions
Can You Invest in Marijuana Legally?
Investors can buy publicly traded securities of cannabis-related companies and funds available through their brokerage accounts. However, the underlying companies can operate under complex and differing federal, state, and international regulatory systems.
The legality and availability of a particular security or transaction can also depend on the investor's jurisdiction and brokerage.
Are Marijuana Stocks Risky?
They can be.
Cannabis businesses may face regulatory uncertainty, competition, financing challenges, price volatility, and company-specific financial problems. OTC and low-priced securities can carry additional disclosure, liquidity, manipulation, and fraud risks.
Are Cannabis ETFs Safer Than Individual Marijuana Stocks?
Not automatically.
An ETF can reduce dependence on the performance of one company by spreading assets among multiple holdings. A cannabis-focused ETF, however, can remain highly concentrated in one industry.
Its value can therefore fall significantly when the sector struggles.
What Should You Look for in a Cannabis ETF?
Review its prospectus, holdings, expense ratio, investment strategy, concentration, trading characteristics, and shareholder reports.
Pay particular attention to the largest holdings. Two funds carrying similar cannabis-related names may provide substantially different exposure.
Do You Need a Special Brokerage Account?
Not necessarily for securities listed on exchanges your brokerage supports.
Access becomes more complicated with OTC or foreign-listed securities. Brokerages have different trading policies, fees, and restrictions, so check availability before funding an account specifically to buy a particular security.
A Careful Approach to Marijuana Investing
Understanding how to invest in marijuana starts with recognizing that cannabis is a theme, not a single type of business.
A grower, pharmaceutical developer, ancillary supplier, and sector ETF can respond very differently to the same market conditions. Their financial strength, regulatory exposure, liquidity, and risk can also vary considerably.
Start with the investment itself rather than the industry's growth story. Review financial statements, regulatory filings, debt, cash flow, fees, fund holdings, and the market where the security trades. Be especially cautious with lightly traded and low-priced securities.
Most importantly, account for the changing legal environment. Federal marijuana policy experienced significant developments in 2026, and broader rescheduling proceedings have continued. Current DEA, DOJ, SEC, IRS, FDA, company filings, and fund documents are therefore more useful for an investment decision than older cannabis guides.
No marijuana stock, ETF, or other investment can guarantee a profit. Careful research and appropriate diversification can help you understand the risks before deciding if cannabis exposure belongs in your portfolio.
